Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Techniques & Tools

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2025 / Articles / Mar / Hail to the Hardy Tardigrade
Discovery & Development Drug Discovery Translational Science Research News Development & Clinical

Hail to the Hardy Tardigrade

By Rob Coker 03/18/2025 2 min read

Share

Recent studies have explored how the tiny tardigrade, a microscopic organism renowned for its resilience (also known as the “water bear”), can inspire new cancer treatments. Researchers from MIT, Brigham and Women's Hospital, and the University of Iowa developed a novel approach to protect cancer patients from the adverse effects of radiation therapy by leveraging the damage suppressor protein (Dsup) produced by tardigrades. mRNA was introduced to encode the Dsup protein into mice, prompting cells to produce it transiently. Cells engineered to express Dsup exhibited increased resistance to radiation, suggesting potential applications in protecting healthy tissue during cancer treatments. The mRNA delivery was facilitated using specially designed polymer-lipid nanoparticles, optimized for targeting specific tissues such as the colon and mouth.

Senior author James Byrne, an assistant professor of radiation oncology at the University of Iowa, said, “[Radiation] affects a huge number of patients, and it can manifest as something as simple as mouth sores, which can limit a person’s ability to eat because it’s so painful, to requiring hospitalization because people are suffering so terribly from the pain, weight loss, or bleeding. It can be pretty dangerous, and it’s something that we really wanted to try and address,”

The findings suggest that this method could potentially mitigate the side effects of radiation therapy in cancer patients, particularly those undergoing treatment for head, neck, and gastrointestinal cancers, where radiation often harms adjacent healthy tissues.

Tardigrades are influencing other areas of medical research too. Research has identified tardigrade proteins capable of inducing a state of suspended animation, or biostasis, in human cells. These proteins form gels that slow down cellular metabolism, making cells more resistant to stressors such as radiation. This reversible process holds more promise for developing therapies that protect healthy cells during cancer treatments. 

A newly discovered tardigrade species has also provided insights into the genetic mechanisms behind their radiation resistance. Genes such as TRID1 and DODA1 have been identified, which contribute to efficient DNA repair and the production of antioxidant pigments, respectively. These findings could inform strategies to enhance human cell resistance to radiation, potentially improving cancer therapies.

Senior scientists Silvia Sanchez-Martinez at the University of Wyoming’s Department of Molecular Biology describes the tardigrade as having unique “superpowers.” She says: “They can survive in extreme environments, for example, in high temperatures, they can survive freezing, and they can survive high pressures.” Species of tardigrade have been found in diverse environments such as at the bottom of the ocean or on mountain tops. Famously, tardigrades have even returned to life following exposure to the vacuum of space. 

They can also survive exposure to a thousand times more radiation than humans, Sanchez-Martinez adds, which explains the interest of the cancer treatment development sector. She foresees potential applications in the preservation of pharmaceuticals and biologics using tardigrade “gels” that can slow down metabolism in human cells.

Inspiration for medicinal development has always been found through the lens of a microscope. But when a microscopic water bear walks across a slide, as part of its epic journey from the depths of the ocean to the cold of space, we will continue to watch and wait for the big things to happen.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Rob Coker

Following a Bachelor’s degree in English Literature and a Master’s in Creative Writing, I entered the world of publishing as a proofreader, working my way up to editor. The career so far has taken me to some amazing places, and I’m excited to see where I can go with Texere and The Medicine Maker.

More Articles by Rob Coker

False

Advertisement

Recommended

False

Related Content

Understanding the H5N1 Threat
Vaccines Drug Discovery
Understanding the H5N1 Threat

February 3, 2025

4 min read

With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?

Battle of the Superbugs
Drug Discovery Technology and Equipment
Battle of the Superbugs

December 1, 2014

0 min read

Can phage endolysins revolutionize the way bacterial infections are treated – and prevent drug resistance?

Antibiotics: Going With the Flow
Drug Discovery Small Molecules
Antibiotics: Going With the Flow

April 2, 2025

2 min read

How fluid flow through the body can affect the ways in which antibiotics work.

Combatting the Side Effects of Treatments for Parkinson’s
Drug Discovery Small Molecules
Combatting the Side Effects of Treatments for Parkinson’s

April 7, 2025

4 min read

Celon Pharma CEO hopes their new compound could be a potential breakthrough for Parkinson’s patients.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.